For grade 2 meningioma, Ki-67 and MCM6 both appear adequate (≥30% for Ki-67, and ≥50% for MCM6, Log-Rank test) for the identification of tissues with potential shorter PFS. This evidence concerns the gene MKI67 and meningioma.